2m 2m 2m 2m 2m 2m 2m
20/20 BIOLABS (AIDX)
NASDAQ
$0.25+$0.0003 (+0.12%)
Price as of Oct 22, 2026 4:00 PM EDT- $3.5MMarket Cap
- N/A1-Year Change
- Medical DevicesIndustry
20/20 BIOLABS (AIDX)
$0.25+$0.0003 (+0.12%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 2.0M N/A | |
Cost of Revenue | 1.4M N/A | |
Gross Profit | 604,541 N/A | |
Sales and Marketing Expense | 3.3M N/A | |
Research and Development Expense | -592,569 N/A | |
Depreciation and Amortization Expense | 22,500 N/A | |
Total Operating Expenses | 3.9M N/A | |
Operating Profit | -3.3M N/A | |
Interest Income | 21,399 N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 21,399 N/A | |
Total Nonoperating Income and Expense | -407,950 N/A | |
Income before Taxes | -3.3M N/A | |
Income Taxes | N/A N/A | |
Extraordinary Items | 16,356 N/A | |
Net Income | -3.7M N/A | |
Net Income from Continuing Operations Applicable to Common | -3.7M N/A | |
Basic EPS and Net Income | -0.76 N/A | |
Diluted EPS and Net Income | -0.76 N/A | |
Basic Weighted Average Shares | 4.9M N/A | |
Diluted Weighted Average Shares | 4.9M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 1.0M N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.0M N/A | |
Total Current Assets | 1.5M N/A | |
Accumulated Depreciation | 524,573 N/A | |
Property and Plant and Equipment and Net | 56,677 N/A | |
Total Long-Term Assets | 23,057 N/A | |
Total Assets | 4.1M N/A | |
Income Taxes Payable | 3,377 N/A | |
Total Short-Term Debt | 74,611 N/A | |
Total Current Liabilities | 2.5M N/A | |
Total Long-Term Debt | 619,355 N/A | |
Total Long-Term Liabilities | 1.7M N/A | |
Total Liabilities | 4.2M N/A | |
Retained Earnings | -33.2M N/A | |
Total Stockholders Equity | -19,225 N/A | |
Total Shares Outstanding | 5.4M N/A | |
Cash Flow | ||
Cash from Operating Activities | -1.9M N/A | |
Capital Expenditures | N/A N/A | |
Cash from Investing Activities | N/A N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 1.2M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow